Latest market price
16.10
-0.68-4.05%
OverviewShort InterestFilings
RAREQT29Ultragenyx Pharmaceutical Inc.·NASDAQ
16.10-4.05%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 30, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 20, 2026SC 13GBeneficial ownership statement (passive)
Oct 19, 20264Statement of changes in beneficial ownership
Oct 19, 20268-KCurrent report
Oct 14, 20268-KCurrent report
Oct 07, 20268-KCurrent report
Sep 17, 20268-KCurrent report
Sep 15, 20264Statement of changes in beneficial ownership
Sep 08, 20264Statement of changes in beneficial ownership
Sep 02, 20268-KCurrent report
Aug 19, 20268-KCurrent report
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 13, 2026SC 13GBeneficial ownership statement (passive)
Aug 11, 20268-KCurrent report
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 05, 202610-QQuarterly report
Aug 04, 20264Statement of changes in beneficial ownership
Aug 04, 20268-KCurrent report
Aug 04, 20264Statement of changes in beneficial ownership
Jul 31, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 30, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 06, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
#1 / 25 of 360
Page
▼
/ 15